Product Information

DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3048 per EA under NDC 68462065301. Its NADAC has been published 50 times since Jul 16, 2025.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

NDC

68462065301

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA210754

On Market Since

5/12/2025

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 50 times since Jul 16, 2025, and over the history we have for it it has declined 9.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3048 per EA
All-time high$0.3373 (Jul 16, 2025)
All-time low$0.3037 (Oct 22, 2025)
52-week high$0.3373
52-week low$0.3037
Median price$0.3117
Average price$0.3138
Largest weekly change-4.7% (Sep 17, 2025)
Weeks tracked50
Tracking sinceJul 16, 2025

Price History

1W

0.0%

1M

-0.3%

3M

-2.8%

6M

-2.4%

1Y

N/A

3Y

N/A

5Y

N/A

All

-9.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3048 per EA (NDC 68462065301), effective Jun 24, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 9.6%. It has been tracked across 50 weekly CMS publications since Jul 16, 2025.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?

Since Jul 16, 2025, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.3037 (Oct 22, 2025) to a high of $0.3373 (Jul 16, 2025), with a median of $0.3117 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DEXTROAMP-AMPHETAMIN 30 MG TAB, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?

DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 68462065301) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.